These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Labeling and testing of 99mTc-streptokinase for the diagnosis of deep vein thrombosis. Persson BR; Kempi V J Nucl Med; 1975 Jun; 16(6):474-7. PubMed ID: 1159502 [TBL] [Abstract][Full Text] [Related]
3. Rapid clearance of human insulin-like growth factor binding protein-3 from the rat circulation and cellular localization in liver, kidney and stomach. Arany E; Zabel P; Hill DJ Growth Regul; 1996 Mar; 6(1):32-41. PubMed ID: 8717448 [TBL] [Abstract][Full Text] [Related]
4. Assessment of radiochemical design of antibodies using an ester bond as the metabolizable linkage: evaluation of maleimidoethyl 3-(tri-n-butylstannyl)hippurate as a radioiodination reagent of antibodies for diagnostic and therapeutic applications. Arano Y; Wakisaka K; Ohmono Y; Uezono T; Akizawa H; Nakayama M; Sakahara H; Tanaka C; Konishi J; Yokoyama A Bioconjug Chem; 1996; 7(6):628-37. PubMed ID: 8950481 [TBL] [Abstract][Full Text] [Related]
5. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice. Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598 [TBL] [Abstract][Full Text] [Related]
6. Failure to visualize experimentally produced emboli and thrombi using 131I streptokinase. Goodman LR; Goodman C; Greenspan RH; Porter CD Invest Radiol; 1973; 8(6):377-83. PubMed ID: 4767011 [No Abstract] [Full Text] [Related]
9. Preparation and use of 123I-labeled highly iodinated fibrinogen for imaging deep-vein thrombi. Harwig JF; Welch MJ; Coleman RE J Nucl Med; 1976 May; 17(5):397-400. PubMed ID: 1262945 [TBL] [Abstract][Full Text] [Related]
10. Turnover of human extrinsic (tissue-type) plasminogen activator in rabbits. Korninger C; Stassen JM; Collen D Thromb Haemost; 1981 Oct; 46(3):658-61. PubMed ID: 7198302 [TBL] [Abstract][Full Text] [Related]
11. Biodistribution and imaging of 1-(2-deoxy-beta-d-ribofuranosyl)-2,4-difluoro-5-[123/125I]iodobenzene (dRF[(123/125)I]IB), a nonpolar thymidine-mimetic nucleoside, in rats and tumor-bearing mice. Stahlschmidt A; Khalili P; Sun W; Machulla HJ; Knaus EE; Wiebe LI Nucleosides Nucleotides Nucleic Acids; 2009 May; 28(5):379-93. PubMed ID: 20183590 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of G3139, a phosphorothioate oligodeoxynucleotide antisense to bcl-2, after intravenous administration or continuous subcutaneous infusion to mice. Raynaud FI; Orr RM; Goddard PM; Lacey HA; Lancashire H; Judson IR; Beck T; Bryan B; Cotter FE J Pharmacol Exp Ther; 1997 Apr; 281(1):420-7. PubMed ID: 9103525 [TBL] [Abstract][Full Text] [Related]
13. In vivo behavior of 99mTc-fibrinogen and its potential as a thrombus-imaging agent. Harwig SS; Harwig JF; Coleman RE; Welch MJ J Nucl Med; 1976 Jan; 17(1):40-6. PubMed ID: 1244446 [TBL] [Abstract][Full Text] [Related]
14. Clearance of IgE from serum of normal and hybridoma-bearing mice. Haba S; Ovary Z; Nisonoff A J Immunol; 1985 May; 134(5):3291-7. PubMed ID: 3980994 [TBL] [Abstract][Full Text] [Related]
15. Comparison of pharmacokinetics of M1, M2, M3, and M4 after intravenous administration of DA-125 or ME2303 to mice and rats. New adriamycin analogues containing fluorine. Yoon EJ; Lee WI; Shim HJ; Lee SD; Kim WB; Yang J; Lee MG Biopharm Drug Dispos; 1996 Jul; 17(5):373-420. PubMed ID: 8830976 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and tissue distribution of cryptophycin 52 (C-52) epoxide and cryptophycin 55 (C-55) chlorohydrin in mice with subcutaneous tumors. Boinpally RR; Polin L; Zhou SL; Jasti BR; Wiegand RA; White K; Kushner J; Horwitz JP; Corbett TH; Parchment RE Cancer Chemother Pharmacol; 2003 Jul; 52(1):25-33. PubMed ID: 12739061 [TBL] [Abstract][Full Text] [Related]
17. Modulation of pharmacokinetics of radioiodinated sugar-conjugated somatostatin analogues by variation of peptide net charge and carbohydration chemistry. Schottelius M; Rau F; Reubi JC; Schwaiger M; Wester HJ Bioconjug Chem; 2005; 16(2):429-37. PubMed ID: 15769098 [TBL] [Abstract][Full Text] [Related]
18. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs. Kobayashi S; Sakai T; Dalrymple PD; Wood SG; Chasseaud LF Arzneimittelforschung; 1993 Dec; 43(12):1367-77. PubMed ID: 8141830 [TBL] [Abstract][Full Text] [Related]
19. In vitro metabolism of a new anticancer agent, 6-N-formylamino-12, 13-dihydro-1,11-dihydroxy-13-(beta-D-glucopyranosil)5H-indolo+ ++[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione (NB-506), in mice, rats, dogs, and humans. Takenaga N; Hasegawa T; Ishii M; Ishizaki H; Hata S; Kamei T Drug Metab Dispos; 1999 Feb; 27(2):213-20. PubMed ID: 9929505 [TBL] [Abstract][Full Text] [Related]
20. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys. Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]